SCHEMBL21701587

SCHEMBL21701587

O=C(Nc1ccc(N2CCCN(c3ccccn3)CC2)cc1C(=O)O)c1ccco1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.53
▸ SMN1; SMN2 Q16637 5/20 0.52
▸ HSD17B10 Q99714 4/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ GAA P10253 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ ALOX15 P16050 2/20 0.48
▸ TSHR P16473 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ MAPT P10636 3/20 0.47
▸ MAPK1 P28482 4/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ CYP2D6 P10635 3/20 0.46
▸ USP2 O75604 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ CYP1A2 P05177 3/20 0.44
▸ CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21683001 0.97 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2HSD17B10KDM4EGAA
SCHEMBL21701579 0.90 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2HSD17B10KDM4EGAA
SCHEMBL21701591 0.86 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2HSD17B10KDM4EGAA
SCHEMBL21701594 0.80 F10 (0.57) ALDH1A1SMN1; SMN2GAAKMT2AMAPT
SCHEMBL21701474 0.79 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2HSD17B10KDM4EGAA
SCHEMBL21683033 0.77 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2HSD17B10KDM4EGAA
SCHEMBL21701581 0.77 POLB (0.56) ALDH1A1SMN1; SMN2HSD17B10KDM4EKMT2A
SCHEMBL21683032 0.70 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2HSD17B10KDM4EGAA
SCHEMBL15528812 0.68 MAPK1 (0.71) ALDH1A1SMN1; SMN2HSD17B10KDM4EGAA
SCHEMBL21701478 0.68 CYP1A2 (0.61) ALDH1A1SMN1; SMN2HSD17B10KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033944-A2 NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2020-02-13 — — WO disclosed
Send feedback